Etiology, Epidemiology, Pathophysiology, Histopathology, Diagnosis, Differential Diagnosis, Treatment and Surgical Oncology of Cervical Cancer

Cervical cancer, is the 4th most common cancer among women worldwide, is occurred in an entire manner by human papillomavirus (HPV). High-risk types of HPV can result in cervical intraepithelial lesions which, over time, can promote to cervical cancer. In the United States and other developed countries, most screening and early detection efforts involve HPV testing and Papanicolaou (Pap) smears. HPV testing recognizes exposure to both low- as well as high-risk types of HPV, whereas Pap smears recognize abnormal cytology. Cervical cancer is a largely preventable disease. Primary prevention and screening are the most effective methods for reducing the healthcare burden as well as mortality applicable to cervical cancer. Since 2006, HPV vaccination has been available to inhibit cervical cancer. Interprofessional team associates must educate young female patients (ideally, prior to initiating sexual activity) and their families regarding the highly efficiencyy of this vaccine. This activity explains about primary prevention strategies, screening guidelines, diagnostic evaluations, current staging, and specific treatment modalities for invasive cervical cancer.